PNR
69
4
D
45
5
MA
57
2
PEG
67
5
ZTS
49
2
BA
49
-3
BBY
36
-4
LRCX
45
6
DE
56
10
CAH
53
6
HPQ
57
-2
DTE
54
4
USB
61
11
MAS
56
5
NTAP
66
2
IVZ
48
2
ALL
51
8
ADI
47
2
JNJ
44
3
PPG
60
3
PNR
69
4
D
45
5
MA
57
2
PEG
67
5
ZTS
49
2
BA
49
-3
BBY
36
-4
LRCX
45
6
DE
56
10
CAH
53
6
HPQ
57
-2
DTE
54
4
USB
61
11
MAS
56
5
NTAP
66
2
IVZ
48
2
ALL
51
8
ADI
47
2
JNJ
44
3
PPG
60
3
Financhill
Back

Cue Biopharma Vs. FibroGen Industry Stock Comparison

Sell
16

CUE
Cue Biopharma

Last Price:
1.05
Seasonality Move:
13.31%
Buy
52

FGEN
FibroGen

Last Price:
0.39
Seasonality Move:
88.99%
Sell
16
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy, Sell or Hold?

  • The current Cue Biopharma [CUE] share price is $1.03. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
52
FibroGen (FGEN) is a Buy

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.39. The Score for FGEN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • FGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

  • The Cue Biopharma share price today is $1.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing selling pressure, which indicates risk of future bearish movement.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 37.67 Sell
Chaikin Money Flow: -356755 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.28 - 1.76) Sell
Bollinger Bands (100): (0.57 - 1.35) Buy

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 57.98 Buy
Chaikin Money Flow: 1244178 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.3 - 0.36) Buy
Bollinger Bands (100): (0.24 - 0.78) Sell

CUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.28 Sell
20-day SMA: 1.51 Sell
50-day SMA: 1.17 Sell
200-day SMA: 1.38 Sell
8-day EMA: 1.24 Sell
20-day EMA: 1.37 Sell
50-day EMA: 1.25 Sell
200-day EMA: 1.45 Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Buy
20-day SMA: 0.33 Buy
50-day SMA: 0.36 Buy
200-day SMA: 1.03 Sell
8-day EMA: 0.35 Buy
20-day EMA: 0.34 Buy
50-day EMA: 0.38 Buy
200-day EMA: 1.23 Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):